Inotuzumab Ozogamicin receives FDA approval for treatment of Acute Lymphoblastic Leukemia in pediatric patients

Akari Therapeutics and Peak Bio merge to expand pipeline with Novel ADC Toolkit

EMA grants dual validation for Daiichi Sankyo and AstraZeneca’s Cancer ADC

Gilead Partners with Abingworth, securing $210M, for Trodelvy trials to develop a Trop-2-directed ADC